Riskpilot← Back to searchSign inGet full accessHJERTEKLINIKKEN I HARSTAD AS
ASActiveOrg 995720264Sjøgata 3, 9405 HarstadMedical specialists activities · NACE 8622Est. 20106 employees
Revenue 2024
NOK 5,5M
+1% vs 2023
EBITDA margin
12.1%
-11% vs 2023
Equity ratio
45.9%
Financial strength
Net profit 2024
NOK 397K
-15% vs 2023
| Revenue | NOK 5,5M | +1% |
| EBITDA | NOK 665K | -11% |
| Net profit | NOK 397K | -15% |
| Total assets | NOK 1,9M | -27% |
| Equity | NOK 894K | +12% |
| Employees | 6 | — |
Legal name
HJERTEKLINIKKEN I HARSTAD AS
Org number
995720264
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
8. juli 2010
Share capital
NOK 100 000
Employees
6 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Legevirksomhet med spesialfelt innenfor hjerteundersøkelser og- behandling, samt annet som naturlig hører herunder.
Address
Sjøgata 3, 9405 Harstad
Phone
+4777012345
Email
post@hjerteklinikken.nhn.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 4 999 | 5 059 | 4 945 | 5 456 | 5 514 |
| Staff expenses | −2 919 | −2 724 | −3 056 | −3 156 | −3 285 |
| EBITDA | 374 | 872 | 289 | 750 | 665 |
| Depreciation & amort. | −157 | −167 | −179 | −202 | −178 |
| EBIT | 217 | 705 | 110 | 549 | 487 |
| Net financials | 53 | 44 | 40 | 52 | 23 |
| Profit before tax | 270 | 749 | 150 | 600 | 510 |
| Tax | 60 | 166 | 35 | 132 | 113 |
| Net profit | 210 | 582 | 115 | 468 | 397 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 6 328 | 6 294 | 2 988 | 2 662 | 1 950 |
| Equity | 1 645 | 1 777 | 1 092 | 797 | 894 |
| Long-term debt | 3 508 | 3 345 | 469 | 258 | 63 |
| Short-term debt | 1 175 | 1 171 | 1 427 | 1 607 | 993 |
| Total debt | 4 682 | 4 516 | 1 896 | 1 865 | 1 055 |
EBITDA margin
12.1%
This company
15.8%
Market median
-23% vs market
20202024
Equity ratio
45.9%
This company
38.2%
Market median
+20% vs market
20202024
Return on equity
44.4%
This company
18.4%
Market median
+141% vs market
20202024
Net profit margin
7.2%
This company
8.1%
Market median
-11% vs market
20202024
Asset turnover
2.83×
This company
1.12×
Market median
+153% vs market
20202024
Debt / equity
1.18×
This company
0.62×
Market median
-90% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
GM Deputy Member | Deputy Member | 2010 |
KA Chief Executive Officer | Chief Executive Officer | 2012 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Marianker As
HJERTEKLINIKKEN I HARSTAD AS Board members of HJERTEKLINIKKEN I HARSTAD AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Gunilla Maria Freij Hofsøy | Deputy Member | 0 companies |
| Kurt Anker Hofsøy | Chief Executive Officer | 0 companies |